ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 791,79
0,64%
Dow Jones
42 364,04
0,45%
DAX
19 473,63
1,32%
Brent Oil
71,405
0,64%
Bitcoin
65 814,63
0,97%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Biostar Pharmaceuticals Inc (CE) (BSPM) Cours

Biostar Pharmaceuticals Inc (CE)

Biostar Pharmaceuticals Inc (CE) (BSPM)

USOTC
0,0001
0,00
( 0,00% )
Mis à jour : 02:00:00
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,0001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,0095
Clôture Veille
0,0001
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
3 318
Volume financier
-
VWAP
-

BSPM Dernières nouvelles

Plus de nouvelles

Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq

XIANYANG, China, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement...

23 Août 2018
GlobeNewswire Inc.

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, April 23, 2018 XIANYANG, China, April 23, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...

23 Avril 2018
PR Newswire (US)

Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform

Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform PR Newswire XIANYANG, China, Feb. 21, 2018 XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar...

21 Février 2018
PR Newswire (US)

Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification

Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification PR Newswire XIANYANG, China, Feb. 7, 2018 XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...

07 Février 2018
PR Newswire (US)

Biostar Regains Compliance with NASDAQ Continued Listing Requirement

Biostar Regains Compliance with NASDAQ Continued Listing Requirement PR Newswire XIANYANG, China, Dec. 4, 2017 XIANYANG, China, Dec. 4, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...

04 Décembre 2017
PR Newswire (US)

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017 PR Newswire XIANYANG, China, Nov. 20, 2017 XIANYANG, China, Nov. 20, 2017 /PRNewswire/...

20 Novembre 2017
PR Newswire (US)

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017 PR Newswire XIANYANG, China, Nov. 15, 2017 XIANYANG, China, Nov. 15, 2017 /PRNewswire/ - Biostar...

15 Novembre 2017
PR Newswire (US)

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, Aug. 28, 2017 XIANYANG, China, Aug. 28, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...

28 Août 2017
PR Newswire (US)

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 PR Newswire XIANYANG, China, May 19, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar...

19 Mai 2017
PR Newswire (US)

Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016

Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016 PR Newswire XIANYANG, China, April 13, 2017 XIANYANG, China, April 13, 2017 /PRNewswire/ - Biostar...

13 Avril 2017
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.00010.00010.000100CS
4000.00010.00010.000100CS
129.9E-599001.0E-60.00011.0E-633180.0001CS
26000.00010.00011.0E-6100842.537E-5CS
52000.00010.00951.0E-682914.481E-5CS
156000.00010.011.0E-640310.00011009CS
260-0.1799-99.94444444440.180.3791.0E-652860.10994211CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EHVVFEhave Inc (CE)
US$ 0,0006
(59 900,00%)
15,71k
NTRRNeutra Corporation (CE)
US$ 0,0002
(19 900,00%)
9,64M
RENORenovare Environmental Inc (CE)
US$ 0,0001
(9 900,00%)
35,75k
MNGGMining Global Inc (PK)
US$ 0,0001
(9 900,00%)
975k
CGSICGS International Inc (CE)
US$ 0,0001
(9 900,00%)
150
JXMNFJaxon Mng Inc (PK)
US$ 0,000001
(-99,99%)
80k
DMKPQDMK Pharmaceuticals Corporation (CE)
US$ 0,000001
(-99,50%)
2,6k
SUNWQSunworks Inc (CE)
US$ 0,000001
(-99,50%)
626,92k
ONPHOncology Pharma Inc (CE)
US$ 0,000001
(-99,50%)
5,1k
BLSPBlue Sphere Corporation (CE)
US$ 0,000001
(-99,50%)
253,55k
AURIAuri Inc New (PK)
US$ 0,0001
(0,00%)
556,32M
SPQSSportsQuest Inc (PK)
US$ 0,0004
(0,00%)
380,84M
DRNKNoHo Inc (PK)
US$ 0,0002
(-33,33%)
318,24M
HMBLHUMBL Inc (PK)
US$ 0,0002
(-33,33%)
198,43M
AAPJAAP Inc (PK)
US$ 0,0004
(100,00%)
185,42M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
BSPM
Biostar Pharmaceuticals (CE)
TG
N13
NanoXplore
TSX
DNTL
dentalcorp
TG
IM8N
Insmed
USOTC
NWSAL
News (PK)
NASDAQ
IONR
ioneer
AMEX
SSO
ProShares Ultra S&P 500
BIT
F10060
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés